InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the full record of transactions filed by Shacham Sharon, Directeur Scientifique. Officer active across 1 companies, notably Karyopharm Therapeutics Inc.. In total, 5 reports have been published. Total volume traded: €269k. The latest transaction was disclosed on 29 March 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
060,000 shares0
Common Stock
SEC:0001209191-22-021755:0·
€57,0066,226 shares@ €9.15610.033% mcap21.2% of flow
Common Stock
SEC:0001209191-22-014626:0·
€96,8579,088 shares@ €10.65770.056% mcap36.0% of flow
Common Stock
SEC:0001209191-22-011639:0·
€57,7426,707 shares@ €8.60920.033% mcap21.4% of flow
Common Stock
SEC:0001209191-22-008119:0·
€57,7426,707 shares@ €8.60920.033% mcap100.0% of flow
Common Stock
SEC:0001209191-22-008119·
5 of 5 declarations
About Shacham Sharon
Sharon Shacham is the Chief Scientific Officer at Karyopharm Therapeutics Inc. She is responsible for leading research and development efforts, contributing to innovation and advancement in therapeutic treatments. Her scientific expertise is essential for the company's success.
